These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 38022729)

  • 1. Tumor Microenvironment Composition and Related Therapy in Hepatocellular Carcinoma.
    Li Z; Zhang Z; Fang L; Zhao J; Niu Z; Chen H; Cao G
    J Hepatocell Carcinoma; 2023; 10():2083-2099. PubMed ID: 38022729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma.
    Xing R; Gao J; Cui Q; Wang Q
    Front Immunol; 2021; 12():783236. PubMed ID: 34899747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma.
    Chen C; Wang Z; Ding Y; Qin Y
    Front Immunol; 2023; 14():1133308. PubMed ID: 36845131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of the tumour microenvironment in hepatocellular carcinoma by tyrosine kinase inhibitors: from modulation to combination therapy targeting the microenvironment.
    Chen R; Li Q; Xu S; Ye C; Tian T; Jiang Q; Shan J; Ruan J
    Cancer Cell Int; 2022 Feb; 22(1):73. PubMed ID: 35148789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy.
    Liu Y; Xun Z; Ma K; Liang S; Li X; Zhou S; Sun L; Liu Y; Du Y; Guo X; Cui T; Zhou H; Wang J; Yin D; Song R; Zhang S; Cai W; Meng F; Guo H; Zhang B; Yang D; Bao R; Hu Q; Wang J; Ye Y; Liu L
    J Hepatol; 2023 Apr; 78(4):770-782. PubMed ID: 36708811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Novel Tumor Microenvironment-Related Long Noncoding RNAs to Determine the Prognosis and Response to Immunotherapy of Hepatocellular Carcinoma Patients.
    Huang S; Zhang J; Lai X; Zhuang L; Wu J
    Front Mol Biosci; 2021; 8():781307. PubMed ID: 35004851
    [No Abstract]   [Full Text] [Related]  

  • 7. Immune checkpoint inhibitor resistance in hepatocellular carcinoma.
    Wang Z; Wang Y; Gao P; Ding J
    Cancer Lett; 2023 Feb; 555():216038. PubMed ID: 36529238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune checkpoint and angiogenic inhibitors for the treatment of hepatocellular carcinoma: It takes two to tangle.
    Sukowati C; Cabral LKD; Tiribelli C
    Ann Hepatol; 2022; 27(5):100740. PubMed ID: 35809835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Complexity of the Tumor Microenvironment in Hepatocellular Carcinoma and Emerging Therapeutic Developments.
    Argentiero A; Delvecchio A; Fasano R; Andriano A; Caradonna IC; Memeo R; Desantis V
    J Clin Med; 2023 Dec; 12(23):. PubMed ID: 38068521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies for improving the efficacy of immunotherapy in hepatocellular carcinoma.
    Zhu Y; Qin LX
    Hepatobiliary Pancreat Dis Int; 2022 Oct; 21(5):420-429. PubMed ID: 35977874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of infiltrating immune cells in tumor microenvironment on metastasis of hepatocellular carcinoma.
    Chen Y; Zhou Y; Yan Z; Tong P; Xia Q; He K
    Cell Oncol (Dordr); 2023 Dec; 46(6):1595-1604. PubMed ID: 37414962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging Role of Cancer-Associated Fibroblasts in Progression and Treatment of Hepatocellular Carcinoma.
    Akkız H
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Exosomes in Immunotherapy of Hepatocellular Carcinoma.
    Tian BW; Han CL; Dong ZR; Tan SY; Wang DX; Li T
    Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36011030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Treatment.
    Leone P; Solimando AG; Fasano R; Argentiero A; Malerba E; Buonavoglia A; Lupo LG; De Re V; Silvestris N; Racanelli V
    Vaccines (Basel); 2021 May; 9(5):. PubMed ID: 34065489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapeutic Approaches for Treating Hepatocellular Carcinoma.
    Shen W; Chen Y; Lei P; Sheldon M; Sun Y; Yao F; Ma L
    Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell-mediated targeted delivery of tadalafil regulates immunosuppression and polyamine metabolism to overcome immune checkpoint blockade resistance in hepatocellular carcinoma.
    Wang X; Zhang Q; Zhou J; Xiao Z; Liu J; Deng S; Hong X; Huang W; Cai M; Guo Y; Huang J; Wang Y; Lin L; Zhu K
    J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36813307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights into checkpoint inhibitor immunotherapy and its combined therapies in hepatocellular carcinoma: from mechanisms to clinical trials.
    Jin H; Qin S; He J; Xiao J; Li Q; Mao Y; Zhao L
    Int J Biol Sci; 2022; 18(7):2775-2794. PubMed ID: 35541908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy for nonalcoholic fatty liver disease-related hepatocellular carcinoma: Lights and shadows.
    Costante F; Airola C; Santopaolo F; Gasbarrini A; Pompili M; Ponziani FR
    World J Gastrointest Oncol; 2022 Sep; 14(9):1622-1636. PubMed ID: 36187401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of angiogenesis-related subtypes of hepatocellular carcinoma and tumor microenvironment infiltration feature in hepatocellular carcinoma.
    Li W; Wu R; Zhang S; Zhao Y; Li L; Hu Z; Su Q; Mang Y; Zhang X; Dong Y; Zheng K; Ran J; Li L
    Clin Transl Oncol; 2023 Jul; 25(7):2099-2115. PubMed ID: 36708372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosome-mediated communication in the tumor microenvironment contributes to hepatocellular carcinoma development and progression.
    Wu Q; Zhou L; Lv D; Zhu X; Tang H
    J Hematol Oncol; 2019 May; 12(1):53. PubMed ID: 31142326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.